PharVision Advisers’s NexGen Energy NXE Stock Holding History

PharVision Advisers’s Portfolio NXE Stock Details NXE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-41,870	Closed	-$375K	–	909
2025 Q3	$375K	Buy	+41,870	New	+$309K	0.21%	103

Other funds holding NXE

Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $73.7B AUM 53.56% 1-Year Est. Return

L1 Capital Melbourne VIC 3000, Australia $2.55B AUM 80.12% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 21.71% 1-Year Est. Return

Hancock Prospecting West Perth, Australia $3.33B AUM 65.96% 1-Year Est. Return

CIBC Asset Management Toronto, Ontario, Canada $40.9B AUM 35.96% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

PharVision Advisers's NXE Position: Q4 2025 in Review

PharVision Advisers sold out of NexGen Energy (NXE) in Q4 2025, closing a stake of 41,870 shares — an estimated $375K sold.

PharVision Advisers first reported a position in NXE in Q3 2025 and held it in 1 quarter. The position peaked at $375K in Q3 2025. 256 funds tracked by Wall St. Rank hold NXE as of Q4 2025.

PharVision Advisers reported no remaining NexGen Energy position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 41,870 NexGen Energy shares in Q4 2025, an estimated $375K.
PharVision Advisers first reported a position in NexGen Energy in Q3 2025 and held it in 1 quarter.
PharVision Advisers's NexGen Energy position peaked at $375K in Q3 2025.
256 funds tracked by Wall St. Rank held NexGen Energy as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.